|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.660 USD | -0.21% |
|
-.--% | +3.10% |
| Apr. 15 | Evotec Taps CureVac Executive as COO | MT |
| Jan. 06 | CureVac ends coverage after BioNTech acquisition |  |
| Capitalization | 867M 1.02B 798M 755M 1.4B 94.69B 1.42B 9.34B 3.66B 45.9B 3.84B 3.76B 162B | P/E ratio 2026 * |
-
| P/E ratio 2027 * | - |
|---|---|---|---|---|---|
| Enterprise value | 424M 501M 390M 369M 684M 46.33B 696M 4.57B 1.79B 22.46B 1.88B 1.84B 79.15B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
-
| Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: CureVac
| 1 day | -0.21% | ||
| 6 months | -13.22% | ||
| Current year | +3.10% |
| Current year | 4.48 |  | 4.68 |
| 1 year | 3.06 | | 5.72 |
| 3 years | 2.22 | | 12.36 |
| 5 years | 2.22 | | 130.48 |
| 10 years | 2.22 | | 151.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2023-03-27 | |
| Director of Finance/CFO | 59 | 2024-11-10 | |
Myriam Mendila
CTO | Chief Tech/Sci/R&D Officer | 60 | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 2015-07-31 | |
Mathias Hothum
BRD | Director/Board Member | 60 | 2015-07-31 |
Craig Tooman
BRD | Director/Board Member | 60 | 2019-05-31 |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -132M -156M -122M -115M -214M -14.46B -217M -1.43B -559M -7.01B -586M -574M -24.71B | - |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Equities
- CVAC Stock
Select your edition
All financial news and data tailored to specific country editions
